Insider · CIK 0001291963

Greene Barry E

CIK 0001291963 Name as filed on the most recent filing

Filed as Greene Barry E (34)

124 transaction lines · from 34 filings · filed 2004-08-27 to 2022-11-15 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

124 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2022-11-10 P, Open-market purchase Sage Therapeutics, Inc.SAGE 500,022 acquired Open Form 4 filing 0001562180-22-007667
2021-08-05 P, Open-market purchase Sage Therapeutics, Inc.SAGE 1,020,054 acquired Open Form 4 filing 0001562180-21-005226
2021-06-16 P, Open-market purchase Sage Therapeutics, Inc.SAGE 495,627 acquired Open Form 4 filing 0001562180-21-004342
2020-09-09 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 3,344,980 disposed Open Form 4 filing 0001735276-20-000098
2020-09-09 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 1,726,440 disposed Open Form 4 filing 0001735276-20-000098
2020-09-09 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 416,175 disposed Open Form 4 filing 0001735276-20-000098
2020-07-07 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 3,562,177 disposed Open Form 4 filing 0001735276-20-000084
2020-05-06 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 3,339,527 disposed Open Form 4 filing 0001735276-20-000060
2019-10-22 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 5,301,581 disposed Open Form 4 filing 0001735276-19-000094
2018-03-14 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 1,315,082 disposed Open Form 4 filing 0001553878-18-000026
2018-03-14 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 1,325,901 disposed Open Form 4 filing 0001553878-18-000026
2018-03-14 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 1,241,106 disposed Open Form 4 filing 0001553878-18-000026
2018-03-14 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 1,027,615 disposed Open Form 4 filing 0001553878-18-000026
2018-03-14 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 405,000 disposed Open Form 4 filing 0001553878-18-000026
2018-03-14 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 189,033 disposed Open Form 4 filing 0001553878-18-000026
2017-10-02 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 10,664,500 disposed Open Form 4 filing 0001553878-17-000054
2017-09-20 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 7,681,500 disposed Open Form 4 filing 0001553878-17-000047
2017-08-01 S, Open-market sale Acorda Therapeutics IncACOR 215,697 disposed Open Form 4 filing 0001209191-17-047299
2017-02-09 S, Open-market sale Acorda Therapeutics IncACOR 16,376 disposed Open Form 4 filing 0001209191-17-009970
2017-01-03 S, Open-market sale Acorda Therapeutics IncACOR 58,113 disposed Open Form 4 filing 0001209191-17-001997
2016-12-01 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 734,747 disposed Open Form 4 filing 0001553878-16-000061
2016-12-01 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 611,345 disposed Open Form 4 filing 0001553878-16-000061
2016-12-01 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 22,036 disposed Open Form 4 filing 0001553878-16-000061
2015-05-26 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 8,422,375 disposed Open Form 4 filing 0001553878-15-000025
2015-04-02 P, Open-market purchase Karyopharm Therapeutics Inc.KPTI 87,938 acquired Open Form 4 filing 0001209191-15-032734
2014-12-19 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 1,120,000 disposed Open Form 4 filing 0001553878-14-000038
2014-11-17 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 1,609,321 disposed Open Form 4 filing 0001553878-14-000021
2014-11-17 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 860,242 disposed Open Form 4 filing 0001553878-14-000021
2014-11-17 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 496,818 disposed Open Form 4 filing 0001553878-14-000021
2014-11-17 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 9,399 disposed Open Form 4 filing 0001553878-14-000021
2014-11-11 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 1,110,000 disposed Open Form 4 filing 0001553878-14-000020
2013-05-28 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 447,840 disposed Open Form 4 filing 0001553878-13-000005
2013-05-28 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 236,820 disposed Open Form 4 filing 0001553878-13-000005
2013-03-14 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 601,450 disposed Open Form 4 filing 0001553878-13-000003
2013-03-08 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 586,270 disposed Open Form 4 filing 0001325812-13-000003
2012-02-21 P, Open-market purchase Alnylam Pharmaceuticals, Inc.ALNY 19,995 acquired Open Form 4 filing 0001325812-12-000007
2012-01-09 P, Open-market purchase Alnylam Pharmaceuticals, Inc.ALNY 4,992 acquired Open Form 4 filing 0001325812-12-000002
2011-12-12 P, Open-market purchase Alnylam Pharmaceuticals, Inc.ALNY 4,995 acquired Open Form 4 filing 0001325812-11-000030
2011-11-14 P, Open-market purchase Alnylam Pharmaceuticals, Inc.ALNY 4,994 acquired Open Form 4 filing 0001325812-11-000023
2011-10-11 P, Open-market purchase Alnylam Pharmaceuticals, Inc.ALNY 4,996 acquired Open Form 4 filing 0001325812-11-000021
2008-08-13 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 1,048,379 disposed Open Form 4 filing 0001325812-08-000039
2008-08-13 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 154,347 disposed Open Form 4 filing 0001325812-08-000039
2007-10-24 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 31,770 disposed Open Form 4 filing 0001325812-07-000038
2007-10-24 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 18,918 disposed Open Form 4 filing 0001325812-07-000038
2007-10-24 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 18,828 disposed Open Form 4 filing 0001325812-07-000038
2007-10-24 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 12,712 disposed Open Form 4 filing 0001325812-07-000038
2007-10-24 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 12,704 disposed Open Form 4 filing 0001325812-07-000038
2007-10-24 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 12,560 disposed Open Form 4 filing 0001325812-07-000038
2007-10-24 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 9,540 disposed Open Form 4 filing 0001325812-07-000038
2007-10-24 S, Open-market sale Alnylam Pharmaceuticals, Inc.ALNY 8,273 disposed Open Form 4 filing 0001325812-07-000038

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 12
  • Open-market sale 112
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Greene Barry E, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001291963

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.